✦ LIBER ✦

Ofatumumab for fludarabine- and alemtuzumab-refractory CLL

✍ Scribed by Jame Abraham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination treatment with alemtuzumab a

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Ofatumumab, a Novel CD20 Monoclonal Anti

✍ Wierda, William; Kipps, Thomas; Mayer, Jiří; Stilgenbauer, Stephan; Williams, Ca 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 53 KB

PMC2 ESTIMATING COST-EFFECTIVENESS BASED

✍ AJ Batty; GJ Thompson; PA Maroudas; TE Delea 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

High-dose glucocorticoids plus Ofatumuma

✍ Vannata, Barbara; Innocenti, Idanna; Autore, Francesco; Sorà, Federica; Chiusolo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Fludarabine in the treatment of refracto

✍ Gillis, S.; Dann, E.J.; Rachmilewitz, E.A.; Polliack, A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Pilot experience with continuous infusio

✍ Alessandra Ferrajoli; William G. Wierda; Ruth LaPushin; Susan M. O’Brien; Stefan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB